Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00414284 · ClinicalTrials.gov registry record · Phase 4
BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
A Phase 4 study, sponsored by Community Research Initiative of New England.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00414284: Clinical Trial Phase 4 study, sponsored by Community Research Initiative of New England.
NCT00414284 is a Phase 4 study that was terminated before completion, run by Community Research Initiative of New England. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00414284, a Phase 4 study, was terminated before completion, sponsored by Community Research Initiative of New England.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
This study will look to see if increasing the standard dose of Kaletra is tolerated and if it will lower viral loads to undetectable levels. This study will also look at the pharmacokinetic data (amount of Kaletra in blood at different times).
Interventions
- DRUG Increased dose of Kaletra
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-06 |
| Est. Completion | 2007-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00414284
The ClinicalTrials.gov registry entry for NCT00414284 describes a study currently listed as terminated, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Community Research Initiative of New England, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Increased dose of Kaletra is the first listed.
NCT00414284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00414284 about?
NCT00414284 is a clinical study titled "BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)". This study will look to see if increasing the standard dose of Kaletra is tolerated and if it will lower viral loads to undetectable levels. This study will also look at the pharmacokinetic data (amount of Kaletra in blood at different times).
What is the current status of trial NCT00414284?
This trial is currently terminated. It is a Phase 4 study. The study started on 2006-06. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00414284?
The interventions under investigation include: Increased dose of Kaletra (DRUG).
Who is sponsoring clinical trial NCT00414284?
This trial is sponsored by Community Research Initiative of New England, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.